Savers Value Village (SVV) Form 144 Shows Recent Insider Sales

Rhea-AI Filing Summary

Savers Value Village, Inc. (SVV) Form 144 notifies the SEC of a proposed sale of 3,615 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $46,931.70. The shares were acquired by option grant on 06/12/2019 and are to be sold on 09/17/2025 for cash. The filing also discloses historical insider sales by Richard Medway totaling 123,752 shares between 07/03/2025 and 09/11/2025 with listed gross proceeds for each transaction. The notice includes the standard insider representation that the seller is not aware of undisclosed material adverse information.

Positive

• Compliance disclosure filed under Rule 144 with required transaction details
• Insider provided acquisition details (option grant date 06/12/2019) and sale method (cash)

Negative

• Insider selling activity totaling 123,752 shares in the past three months, which may be of interest to investors

Insights

Securities Analyst

TL;DR: Routine compliance filing showing a planned sale of 3,615 shares and prior insider sales totaling 123,752 shares.

This Form 144 documents a proposed sale by an insider of 3,615 common shares via a broker on the NYSE for cash, acquired originally via an option granted in 2019. The filing lists multiple prior sales by the same insider across July to September 2025 that together equal 123,752 shares and shows gross proceeds per transaction. Given the issuer's reported outstanding shares of 155,555,984, the cumulative sales represent a de minimis fraction of total outstanding shares, suggesting limited direct dilution or market impact. The filing serves primarily as a compliance disclosure under Rule 144.

Corporate Governance Specialist

TL;DR: Disclosure appears complete for Rule 144 purposes and contains the customary seller certification.

The document contains required details: class of security, broker name, acquisition date and nature, sale date, number of shares and market value, and prior sales history. The insider affirms absence of undisclosed material adverse information and an intent to sell under Rule 144. There is no indication in this filing of any corporate action, governance change, or material event affecting the company; it is a transaction-level disclosure focused on insider liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3615	46931.70	155555984	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/17/2025	Option Granted - 06/12/2019	Issuer			3615	09/17/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/03/2025	17619	187642.35
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/18/2025	1800	18950.94
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/22/2025	600	6306.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/23/2025	4228	44415.99
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/31/2025	2637	27641.56
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/01/2025	45735	505108.16
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/04/2025	15000	172200.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/29/2025	15000	179700.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/02/2025	17500	218912.75
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/05/2025	2300	29900.46
Richard Medway 11400 S.E. 6th Street Suite 125 Bellvue WA 98004	Common	09/11/2025	1333	17363.79

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by SVV disclose?

The filing discloses a proposed sale of 3,615 common shares on 09/17/2025 through Fidelity with an aggregate market value of $46,931.70.

Who conducted recent insider sales for SVV and how many shares were sold?

Richard Medway sold a total of 123,752 common shares across multiple transactions from 07/03/2025 to 09/11/2025, with gross proceeds reported per trade.

How were the 3,615 shares being offered acquired?

The shares were acquired via an option grant dated 06/12/2019 and the planned sale is for cash on 09/17/2025.

On which exchange will the proposed sale occur?

The proposed sale is listed for the NYSE through Fidelity Brokerage Services LLC.

Does the filing state any undisclosed material information about SVV?

The filer represents they do not know any material adverse information not publicly disclosed as part of the Form 144 signature statement.